skip to content
Primary navigation


DrugVeltassa™ (patiromer) [Relypsa, Inc.]

March 2016

Therapeutic area - Hyperkalemia

Approval criteria

  • Patient has a diagnosis of chronic hyperkalemia AND one of the following:
    • Patient has tried and failed sodium polystyrene sulfonate OR 
    • Patient has a known hypersensitivity to sodium polystyrene sulfonate

Quantity limit

  • Maximum of one packet daily (34 packets per 34 days)


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top